Serum Institute To Produce Sputnik V From September, Says Russian Maker

Serum Institute To Produce Sputnik V From September, Says Russian Maker

Newsdesk |
July 13, 2021

Russian vaccine Sputnik V will be produced at the manufacturing units of Pune-based Serum Institute of India from September. The Russian RDIF (Russian Direct Investment Fund) said they "intend to produce over 300 million doses in India per year". Technology transfer has already started and the first batch of vaccines is expected in September.

New Delhi, 13  July 2021

As per news report of NDTV, "As part of the technical transfer process, SII has already received cell and vector samples from the Gamaleya Center. With their import approved by the Drug Controller General of India), the cultivation process has begun," read a statement from RDIF. "I am delighted to partner with RDIF to manufacture the Sputnik vaccine. We hope to make millions of doses in the coming months with trial batches starting in the month of September," said Serum Institute chief Adar Poonawalla. "With high efficacy and a good safety profile, it is critical that the Sputnik vaccine is accessible in full measure for people across India and the world. Given the uncertainty of the virus, it is important for international institutes, and governments to collaborate and further bolster up our fight against the pandemic," he added.

Source -NDTV


If you like the story and if you wish more such stories, support our effort Make a donation.


If you believe investigative journalism is essential to making democracy functional and accountable support us. »